Production of endothelium-derived factors from sodded expanded polytetrafluoroethylene grafts  by Lewis, D.A. et al.
Production of endothelium-derived 
factors from sodded expanded 
polytctrafluoroethylene grafts 
D. A. Lewis, PhD,  R. C. Lowell, MD,  R. A. Cambria,  MD,  P. C. Roche, PhD,  
P. Gloviczki, MD,  and V. M. Miller, PhD,  Rochester, Minn. 
Purpose: Experiments were d signed to determine whether endothelium isolated from 
adipose tissue and sodded onto expanded polytetrafluoroethylene grafts release ndothe- 
lium-derived vasoactive factors. 
Methods: Thin-walled expanded polytetrafluoroethylene grafts (6 mm internal diameter, 6 
cm length, 30 ~m pore size), one sodded with autogenous endothelial cells, the other 
unsodded, were implanted bilaterally in carotid arteries of 30 male mongrel dogs. Dogs 
were treated with 325 mg aspirin daily. After 6 weeks grafts were excised and perfused in 
a bioassay system. Effluent from the grafts stimulated with either acetylcholine, throm- 
bin, adenosine 5-diphosphate, or the calcium ionophore A23187 was superfused over 
rings of canine femoral arteries without endothelium contracted with phenylephrine. 
Effluent from the grafts was analyzed by radioimmunoassay for thromboxane B2, 6-keto- 
prostaglandin FI~ , endothelin-1, and C-type natriuretic peptide. 
Results: Ninety percent of the sodded grafts and 87% of the unsodded grafts were patent 
after 6 weeks. Bioassay rings superfused with effluent from sodded grafts stimulated with 
acetylcholine relaxed significantly more than rings superfused with effluent from similarly 
stimulated unsodded grafts. Biochemical analysis of the effluent showed an increase in 
6-keto prostaglandin Fh  and C-type natriuretic peptide and a decrease in endothelin-1 
and thromboxane B 2 release from the sodded compared with the unsodded grafts. 
Scanning electron microscopy showed a continuous layer of endothelial cells lining only 
the sodded grafts. Staining for ot-actin and heavy-chain myosin showed a differentiated 
layer of smooth muscle below the endothelial layer on the sodded grafts. Finally, there 
was positive staining for C-type natriuretic peptide and endothelin-1 in the endothelium 
of the sodded grafts. 
Conclusions: These results indicate that endothelial cells of sodded expanded polytetra- 
fluoroethylene grafts produce ndothelium-derived asoactlve factors. In addition, recep- 
tor-coupled synthesis/release of these factors is retained in sodded endothelial cells. 
(J Vasc Surg 1997;25:187-97.) 
When autogenous blood vessels are not available 
for arterial reconstruction i  peripheral arterial occlu- 
sive disease, prosthetic grafts offer an alternative con- 
duit. These grafts, however, have low long-term 
patency. 1,2 To improve patency "seeding" or "sod- 
ding" with autogenous endothelial cells onto the 
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prosthetic graft lumen has been suggested. Clinical 
results with small-diameter (6 mm or less) endothe- 
lial seeded grafts vary. One-year studies have shown a 
82% patency rate for sodded grafts placed as femo- 
ropopliteal bypass versus 31% in unsodded expanded 
polytetrafluoroethylene (ePTFE) grafts? Another 
study showed no difference in patency rates. 4
Studies examining sodding of prosthetic grafts 
have focused on the clinical impact of  the technique, 
patency, and defining anatomic characteristics and 
function of these endothelial monolayers as it relates 
to antithrombogenicity. This study was designed (1) 
to identify factors released by the cells lining sodded 
grafts that might contribute to their antithromboge- 
nicity, and (2) to identify stimuli that might promote 
release of  antithrombogenic factors. It was hypothe- 
sized that endothelial cells on the sodded grafts 
187 
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would produce ndothelium-derived r laxing factors 
in response to pharmacologic-receptor s imulation. 
METHODS 
All animals were cared for following The Princi- 
ples of Laboratory Animal Care and The Guide For 
the Care and Use of Laboratory Animals. 
Surgery. Dogs (n = 30, mean weight 23.2 _+ 
0.7 kg) were anesthetized with methohexital sodium 
(10 mg/kg) and intubated. Surgical evels of anes- 
thesia were maintained with halothane (1% to 1.5%) 
for the remainder of the surgical procedure. Bicillin 
(1.2 million U) was given prophylactically b  intra- 
muscular injection to each animal before surgery. A 
catheter was inserted into the femoral artery to mon- 
itor arterial pressure and obtain blood samples. A 
catheter was also placed in the cephalic vein so that a 
continuous infusion of saline solution (7 cc/kg/hr)  
could be maintained. A midline epigastric incision 
was made, and a minimum of 20 gm of omental or 
falciform fat was removed for harvesting of endothe- 
lial cells. 
Bilateral incisions were made in the neck to ex- 
pose the carotid arteries. Blood flow was measured 
through the common carotid artery with an ultra- 
sonic flow probe (Transonic Systems Inc., Ithaca, 
N. Y.). Heparin (100 U /kg  intravenously) was ad- 
ministered and permitted to circulate for 5 minutes, 
after which the carotid artery was clamped and bi- 
sected. Thin-walled ePTFE (Impra Inc., Tempe, Ariz.) 
interposition grafts (6 cm in length, 6 mm internal 
diameter, and 30 ~m pore size) were placed in the 
carotid arteries with continuous nmning 6.0 prolene 
sutures in an end-to-end fashion. One graft was im- 
planted unsodded, whereas the contralateral side was 
sodded with autogenous endothelial cells and then im- 
planted. After both grafts were implanted, measure- 
ments of blood flow were repeated istal to the grafts. 
Dogs recovered from surgery and were given 
aspirin (325 rag/day) for the remainder of the study. 
This treatment mimics treatments u ed clinically. Af- 
ter 6 weeks animals were anesthetized with pentobar- 
bital (30 mg/kg),  and the grafts were removed either 
for histology or bioassay experiments. 
Endothelial sodding. Isolation of endothelial 
cells and sodding onto ePTFE grafts was performed 
according to the method of Williams. s In brief, 100 
ml of arterial blood was removed and centrifuged to 
obtain serum. Fat from the omentum or falciform 
pad was placed in a sterile beaker with "harvest me- 
dia" (20% fetal bovine serum, GIBCOBRL, Life 
Technologies, Grand Island, N. Y. in Media 199; 
GIBCOBRL), chopped into fine pieces, and washed 
through a sieve. The resulting slurry was placed in 
"digesting media" (Dulbecco's phosphate-buffered 
saline solution, GIBCOBRL; collagenase CLS1; 8 
mg/ml,  Worthington Biochemical Corp., Freehold, 
N. J.; human serum albumin; 8 mg/ml,  Sigma 
Chemical Corp., St. Louis, Mo.) and digested by 
gently shaking the slurry for 30 minutes at 37 ° C. 
The digested slurry was centrifuged at 1800 RPM for 
4 minutes, and the resulting pellet was resuspended 
in Dulbecco's solution. The resuspended pellet/ 
Dulbecco's was again centrifuged at 1800 RPM for 4 
minutes. This final pellet was resuspended in sodding 
media (autogenous dog serum and Eagle's media 
199, GIBCOBRL; 1:6). Cells were then infused into 
the ePTFE graft followed by four graft volumes of 
sodding media infused (1 ml/min) at a pressure of 
-5  psi to force the endothelial cells into the graft 
wall. 
Bioassay experiments.  Grafts were excised, 
gently irrigated with a chilled modified Kreb's Ringer 
bicarbonate solution in txmol/L: 118.3 NaC1, 4.7 
KCI, 2.5 CaC12, 1.2 MgSO4, 1.2 KH2PO4, 25.0 
NaHCOs, 0.026 edetate calcium disodium, and 
11.1 glucose (control solution). Sodded and un- 
sodded ePTFE grafts from the same animal were cut 
0.5 cm from each anastomosis and cannulated onto 
stainless steel tubes. The cannulated grafts then were 
placed in a bioassay apparatus. 6 Grafts were main- 
tained at 37 ° C in the control solution, which was 
gassed with 95% 02 and 5% CO 2. The bioassay 
apparatus also contained two stainless teel tubes 
through which control solution was perfused di- 
rectly. The tubes and grafts were perfused with the 
control solution at a constant rate of 3 ml/min with a 
roller pump (Gilson Miniplus 2, Middleton, Wis.). 
Care was taken to ensure flow through the graft was 
in the same direction in vitro as in vivo. Two rings of 
femoral artery (bioassay rings) were removed from an 
unoperated, unmedicated og anesthetized with 
pentobarbital nd then exsanguinated on the same 
day as the experiment. The endothelium was re- 
moved, and both were suspended for the measure- 
ment of isometric force directly below the perfused 
stainless teel. The ring/stirrup/force transducer as- 
sembly could move freely, permitting the bioassay 
rings to be superfused with either effluent from a 
graft (graft superfusion) or from a stainless steel tube 
(direct superfusion). Drugs were added to the per- 
fusing fluid of the stainless teel tubing to determine 
their direct effect on the vascular smooth muscle of 
the bioassay ring or above the graft, exposing the 
graft lining to the agonist o determine whether the 
cells on the graft lining produce endothelium-de- 
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Sodded Unsodded 
Fig. 1. Scanning electron micrographs (×500) of sodded (left panel) and unsodded (right 
panel) ePTFE grafts. Sodded graft is lined by cells forming typical cobblestone appearance of 
endothelial cells. No consistent lining was observed on unsodded grafts. 
rived factors that affect the smooth muscle of the 
bioassay ring. 
The bioassay ring was stretched to 10 gm of 
resting tension in 2-gin increments while being su- 
perfused with effluent from the direct line. 7 Bioassay 
rings and not the grafts were contracted with phen- 
ylephrine (1 × 10 -6 mol/L). The absence ofendo- 
thelium on the bioassay rings was determined by lack 
of relaxation to acetylcholine (1 × 10 -6 mol/L) 
during direct superfusion. 
Bioassay rings were contracted with phenyleph- 
fine under their respective direct lines. Once the 
contraction was stable, an agonist was injected into 
the perfusate above the direct lines, and the response 
was recorded. Rings were then placed under their 
respective grafts, and contracted with phenylephrine, 
and the same agonist was injected into the perfusate 
above the grafts. The effluent from the sodded and 
unsodded grafts also was collected for subsequent 
biochemical analysis. These steps were repeated for 
each agonist. Agonists were administered in the same 
order for all sodded and unsodded grafts. All sodded 
and unsodded grafts were stimulated with acetylcho- 
line (1 × 10 -6 mol/L) and the calcium ionophore 
A23187 (i × 10 -6 mol/L). Half of the grafts were 
also stimulated with adenosine 5-diphosphate (1 × 
10 -4 mol/L) and the other half with thrombin (0.1 
U/ml). Thus each graft was stimulated with only 
three agonists. No experiment lasted more than 5 
hours. A minimum of 20 minutes was permitted to 
elapse between agonists. 
Drugs and chemicals. The following drugs 
were used: acetylcholine, adenosine 5-diphosphate, 
the calcium ionophore A23187, dimethyl sulfoxide 
(DMSO), phenylephrine, and thrombin (all from 
Sigma Chemical). Drugs were prepared fresh daily 
and kept on ice. The calcium ionophore 3,23187 was 
dissolved in DMSO and diluted in distilled water 
(final concentration ofDMSO: 8.2 × 10 -3 mol/L). 
The final concentration of DMSO has been shown 
not to affect smooth muscle. 8Concentrations of the 
drug are reported as the final molar concentration i  
the superfusing solution. 
Biochemical assays. Assays of effluent from the 
bioassay system were obtained for thromboxane B2 
(the stable metabolite of thromboxane A2) , 6-keto 
prostaglandin Fz~ (the stable metabolite ofprosta- 
cyclin), endothelin-1, and C-type natriuretic pep- 
tide by radioimmunoassay (DuPont NEN, E.I Du- 
Pont deNemours & Co., Boston, Mass.; 
Amersham International, Amersham, U. K.).  9 The 
lower limits of the assays arc 10 pg/ml for throm- 
boxane B2, 20 pg/ml for 6-keto prostaglandin 
FI~ , 0.5 pg/ml for endothelin-1, and 2 pg/ml for 
C-type natriuretic peptide. 
Histology. Sodded (n = 3) and unsodded grafts 
(n = 3) not used in bioassay experiments were cut 
into three 2-centimeter sections (proximal, mid, and 
distal), fixed in formalin, and prepared for scanning 
electron microscopy. 
Immunohistochemistry. All immunohistochem- 
istry was performed in the Immunostaining Labora- 
tory at the Mayo Clinic, Rochester, Minnesota. Mid- 
portions of sodded and unsodded grafts used in 
bioassay experiments were cut into two pieces at the 
conclusion of the experiment. One piece was snap- 
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frozen, and the other was fixed in 10% formalin for 
24 hours and subsequently embedded in paraffin. 
Frozen pieces of grafts were stained for c~-actin 
and heavy-chain myosin (the primary antibodies for 
these were gifts from Dr. Gary K. Owens, University 
of Virginia). Sections (5 Ixm) were placed on a si- 
lanized slide and stored in a dehumidified chamber 
overnight. Sections were fixed in acetone (4 ° C) for 5 
minutes, allowed to air-dry, and then incubated in 
phosphate-buffered saline solution (PBS)/ethyl- 
enediamine tetraacetic acid for 11/2 minutes and 
washed with PBS. Sections were then incubated in 
0.1% azide/3% H202 for 10 minutes and rinsed in 
PBS incubated with 5% goat serum for 15 minutes. 
The serum was drained, and the primary antibody 
(1:200 dilution) was applied and incubated for 60 
minutes at room temperature. The sections were 
washed three times for 10 minutes each in PBS, and 
the secondary antibody (biotinylated F(ab)2 frag- 
ment) in a 1:200 dilution was added and incubated 
for 30 minutes at room temperature. The sections 
were washed three times for 10 minutes each in PBS. 
Streptavidin was added (1:250 dilution) and incu- 
bated for 15 minutes at room temperature. The sec- 
tions were again washed three rimes for 10 minutes 
each in PBS. Finally, all slides were stained for 15 
minutes in 3-amino-9 ethylcarbazole (AEC) solution 
and counterstained for 1 minute in mercury-ftee he- 
matoxylin-eosin. The sections were washed three 
times for 10 minutes each in distilled water. Slides 
were mounted in aqueous glycerol gelatin media. 
Segments of grafts placed in formalin were exam- 
ined for endothelin-1, endothelial nitric oxide syn- 
thase (ecNOS), and C-type natriuretic peptide-22 
(CNP). All segments of grafts were cut into 5 txm 
sections, deparatfinized in xylene, and then rehy- 
drated through graded alcohols. Endogenous perox- 
idase activity was blocked by incubating the sections 
in 50% MeOH/H202 for 10 minutes and then rins- 
ing with tap water. Slides that were to be stained for 
endothelin-1 and CNP were pretreated by micro- 
waving in 10 txmol/L citrate (pH = 6.0) and were 
then washed in tap water for 1 to 2 minutes. Nonspe- 
cific protein binding was blocked on all slides with 
5% normal goat serum (NGS)/PBS/0.05% Tween 
20 (pH = 7.4) for 10 minutes at room temperature 
and then blotted dry. Slides that were stained for 
endothelin-1 were incubated in anti-endothelin-1 
polyclonal antibody (Phoenix Pharmaceuticals, Inc., 
Mountain View, Calif.), and those stained for CNP 
were incubated in anti-C type natriuretic peptide-22 
polyclonal antibody (Phoenix Pharmaceuticals, Inc., 
Mountain View, Calif.), both in a 1:2000 dilution 
overnight at room temperature and then drained, 
rinsed, and incubated in biotinylated goat anti-rabbit 
immunoglobulin G (1:200 dilution) for 30 minutes. 
Slides stained for eNOS were incubated in anti- 
eNOS monoclonal antibody (Transduction Labora- 
tories, Lexington, Ky.) 5 txg/ml dilution for 60 
minutes, then drained, rinsed, and incubated in goat 
anti-mouse immunoglobulin G (1:200 dilution) for 
30 minutes. All slides were then rinsed well in tap 
water, incubated for 30 minutes in peroxidase-la- 
beled streptavidin (1:500 dilution), stained for 15 
minutes in AEC solution, and counterstained for 1 
minute in mercury-free hematoxylin-eosin. After 
rinsing for 5 minutes in tap water, slides were 
mounted in aqueous glycerol gelatin media and si- 
lanized slides. 
For all immunostaining sections with a single 
antibody were batched to control for variability in 
antibody preparation. To control for specificity of 
the antibody stain adjacent sections of tissue were 
incubated in paral, el in 1% goat serum/PBS/Tween 
in the absence of primary antibody or normal rabbit 
serum diluted 1:2000. 
Calculations and statistical analysis. Only data 
from paired grafts (sodded and unsodded from the 
same animal) were included in the analysis. For ex- 
ample, during data collection some bioassay rings 
Big. 2. Micrographs (Xl00) of sodded (left panel) and unsodded (right panel) ePTFE grafts 
stained with antibody for heavy-chain myosin (a, b), C-type natriuretic peptide (CNP: c, d), 
endothelin-1 (e, f), and endothelial nitric oxide synthase (ecNOS: g, h). Bar denotes extent of 
ePTFE graft; arrow indicates infiltration of white cells. Sodded grafts exhibited positive, specific 
staining for heavy-chain myosin, indicating differentiated smooth-muscle c lls. Sodded grafts 
also exhibited positive staining for CNP throughout section; only cells of adventia had positive 
staining CNP in unsodded grafts. Positive staining for endothelin-1 was present in cells lining 
lumen and smooth muscle of sodded graft. There was nonspecific staining along luminal border 
in unsodded grafts. Positive staining for ecNOS was present in cells lining lumen and smooth- 
muscle/ePTFE border in sodded graft. Unsodded grafts howed nonspecific staining through- 
out section. 
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Fig. 3. Sample trace of response of bioassay ring to effluent from direct line (superfusion 
through metal tube) and effluent from sodded graft stimulated only by flow of perfusing 
solution and following stimulation with acetylcholine (1 × 10 -6 tool/L). 
developed spontaneous activity; these data were not 
interpretable. Therefore data from the point where 
spontaneous activity occurred were not used from 
either graft for the bioassay experiments. Likewise, if 
one of the grafts was not patent, neither side was 
included in any of the analyses. 
All data are expressed as mean + SEM; n equals 
the number of dogs from which the grafts or samples 
were taken. Responses of the bioassay rings are ex- 
pressed as a percent change in tension from the 
contraction to phenylephrine. Paired t tests were 
performed on the maximal relaxations and on all the 
effluent assay experiments. Two-way analysis of vari- 
ance was used to compare blood flow and mean 
arterial pressure. The a level for all tests was set at 
O.O5. 
RESULTS 
Patency. Twenty-six (90%) of the 29 sodded 
grafts (one graft was not put into the analysis because 
of structural failure) were patent, and 26 (87%) of the 
30 unsodded grafts were patent. 
Blood flow and blood pressure. Mean arterial 
pressure was not different at the time of surgery 
compared with 6 weeks after surgery (84.7 and 79.7 
mm Hg, respectively). Blood flow did increase 
through the unsodded grafts from immediately after 
implantation (183.2 + 16.6 ml/min; n = 19) to 
death 249.7 + 29.4 ml/min; n = 19) but did not 
change in the sodded grafts (after implantation: 
204.9 + 16.4 ml/min; n = 19 and death: 227.7 + 
24.8 ml/min; n = 19). 
Histology. Scanning electron microscopy showed 
a confluent layer of cells lining sodded grafts. There 
were no confluent cells lining unsodded grafts (Fig. 1). 
Immunohistochemistry. In general, none of 
the sections tained in the absence of primary anti- 
bodies. In all sections from sodded grafts a layer of 
cells staining positive for heaw-chain myosin (Fig. 
2a) was observed between the cells lining the lumen 
and the graft material. A general feature of the un- 
sodded grafts was white cells infiltrating the graft 
from the graft/adventitia boarder (Fig. 2b, arrow). 
In sodded grafts positive staining for CNP (Fig. 
2c, d) was observed in the cells lining the lumen, cells 
in the underlying layer, and those infiltrating the 
ePTFE and adventia. In the unsodded graft posi- 
tive staining for CNP was observed only in cells of 
the adventia. In sodded grafts positive specific 
staining for endothelin-1 (Fig. 2e) was observed 
only in ceils lining the lumen and the underlying 
layer but not in the ePTFE and adventia. Cells 
stained for endothelin-1 along the lumenal border 
but not in the ePTFE or adventia in unsodded 
grafts (Fig. 2f). Positive staining for ecNOS ap- 
peared along the lining cells/ePTFE border in 
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Fig. 4. Relaxations of bioassay rings to effluent from sodded and unsodded ePTFE grafts 
stimulated with acetylcholine (1 × 10-6 tool/L; mean -+ SEM). Values are expressed as percent 
change in tension after contraction with phenylephrine (1 × 10 -6  or S tool/L). *Represents 
significant difference between sodded and unsodded grafts, p < 0.05. 
sodded grafts (Fig. 2g). The unsodded grafts (Fig. 
2h) showed diffuse nonspecific staining through- 
out the graft. 
Bioassay. Bioassay rings (7 of 12) relaxed on 
exposure to superfusate from sodded grafts in the 
absence of agonist stimulation (Fig. 3); only 3 of 12 
rings relaxed when exposed to effluent from the un- 
sodded grafts in the absence of agonist stimulation. 
Bioassay rings superfuscd with the effluent of sodded 
grafts stimulated with acetylcholine (1 × 10 -6 mol/L) 
relaxed significantly more than rings superfused with 
effluent from the unsoddcd grafts stimulated with ace- 
tylchofine (Fig. 4). Relaxations of the bioassay tings to 
adenosinc 5-diphosphate, thrombin, and the calcium 
ionophore 3223187 were not statistically different be- 
tween sodded and unsodded grafts (Table I). Acetyl- 
choline, adenosine-5-diphosphate, hrombin, and 
A23187 did not cause relaxation ofbioassay rings when 
applied through the direct line. 
Biochemical assays. 6-keto prostaglandin FI~ 
was measurable in effluent from both sodded and 
unsodded grafts stimulated with any of the agonists. 
After perfusion with A23187 was performed, signifi- 
cantly more 6-keto prostaglandin FI~ was released 
from the sodded as opposed to the unsodded grafts 
(Fig. 5). The amount of thromboxane ]32 released 
was significantly less in sodded grafts compared with 
the unsodded grafts after perfusion with acetylcho- 
line or 3,23187 was performed. Endothelin-1 and 
Table I. Responses of paired canine femoral 
arteries (without endothelium) to effluent 
from sodded or unsodded ePTFE grafts 
stimulated with adenosine-5-diphosphate, 
thrombin, or A23187 
Sodded ePTFE Unsodded ePTFE 
grafts grafts 
-34.6  + 11.0 -9 .4  -+ 5.6 Adenosine- 5- Diphosphate 
(10 4 tool/L) 
(n = 6) 
Thrombin 
(0.1 U/ml )  
(n = s) 
A23187 
(10 -6 mol/L)  
(n = 9) 
-16.9 ± 11.0 3.2 _+ 6.2 
-17.2  ± 12.0 3.3 ± 2.7 
Data are paired and represent percent change in tension from the 
contraction with phenylephrine (1 × 10 -6 or --S tool/L) and are 
presented as mean + SEM; n equals the number of individual 
dogs. 
C-type natriuretic peptide were above dctectable 
limits when stimulated with either acetylcholine (3 of 
11 samples), thrombin (2 of 7 samples), adenosine 
5-diphosphate (2 of 6 samples), or the calcium iono- 
phore (3 of 13 samples) for both sodded and unsod- 
ded grafts (Table II). 
DISCUSSION 
Results of this study extend previous observations 
beyond morphologic and histologic haracteristics of
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Fig. 5. Biochemical analysis of effluent with radioimmunoassay for 6-keto prostaglandin FI~ 
(top panel) and thromboxane B 2 (bottom panel; mean ± SEM). Grafts were stimulated with 
either acetylcholine (1 × 10 -6  tool/L; n = 11), thrombin (0.1 U/ml; n = 7), adenosine 
5-diphosphate (1 × 10 -4  mol/L; n = 6), or calcium ionophore A23187 (1 × 10 6 mol/L; 
n = 13). *Represents significant difference in production of prostacyclin and thromboxane in 
sodded grafts compared with unsodded grafts. 
sodded grafts i°-16 to indicate that cells lining sodded 
ePTFE grafts release vasoactive substances in re- 
sponse to mechanical and receptor activation. This 
conclusion is based on functional responses of bioas- 
say tissue, direct biochemical analysis of graft efflu- 
ent, and immunostaining of the grafts. 
It was not possible to identify the cells lining the 
grafts as endothelium by use of cell-specific antibody 
for yon Willibrand factor. However, even with this 
limitation cells lining the grafts have the morpho- 
logic characteristics of endothelial cells and respond 
to mechanical and agonist stimulation as do endo- 
thelial cells of arteries. For example, before the first 
agonist was applied to the cells, relaxations were 
observed in many of the bioassay tings after they 
were placed under the sodded grafts. Thus flow of 
perfusate through the sodded graft induced release 
of relaxing factors from cells lining the grafts as 
occurs in perfused arteries with endothelium. 17One 
of  the most interesting results of this study is that 
cells from sodded grafts produce relaxing factors in 
response to the agonist acetylchollne as do arterial 
endothelial cells? 8 This finding is important, because 
damaged endothelium and endothelial cells in cul- 
ture do not release ndothelium-derived r laxing fac- 
tors when stimulated with acetylcholine. 19-22 
Relaxation of bioassay rings in response to stimu- 
lation of grafts with adenosine 5-diphosphate, 
thrombin, and the calcium ionophore were not sig- 
nificantly different between graft types. The reasons 
for this are not clear. The duration of the bioassay 
experiments was relatively short; however, it is possi- 
ble that constant flow through the grafts depleted 
substrate or other cofactors or receptor-coupling 
mechanisms necessary for the production/release o f  
endothelium-derived r laxing factors. It is also possi- 
JOURNAL OF VASCULAR SURGERY 
Volume 25, Number l Lewis et ak 195 
Table i i .  Endothelin-1 and C-type natriuretic peptide values from the effluent of sodded and 
unsodded ePTFE grafts explanted from dogs and stimulated with acetylcholine, 
adenosine- 5 diphosphate, thrombin, or A2 318 7 
Endothelin-1 (pg/ml) 
Sodded ePTFE grafts Unsodded PTFE grafts 
C-type natriuretic peptide (pg/ml) 
Sodded. ePTFE grafts Unsodded PTFE grafts 
Ace@choline 14.33 ± 2.84 13.97 +_ 1.53 56.67 _+ 3.93 38.33 + 6.36 
10 -6 ~moi /L  
(n = 3) 
Adenosine-5-Diphosphate 13.15 + 4.45 10.65 -+ 1.95 115.00 -+ 76 100.50 ± 36.50 
10 .4 b~mol/L 
(n = 2) 
Thrombin 10.55 ± 1.45 16.20 _+ 7.10 71.50 ± 4.50 62.50 ± 15.50 
o.1 u/M 
(n = 2) 
A23187 10,60 ~+ 1.97 11.10 ± 2.20 135.00 _+ 37 90.00 --- 43.40 
10 -6 ~mol /L  
(n = 3)  
Data are paired and presented as mean + SEM. 
ble that the bioassay tissue, in this case canine femo- 
ral artery, may not have been the most sensitive tissue 
to respond to all the factors being released from the 
cells on the grafts (for example, hyperpolarizing fac- 
tor). Finally, because there was most likely a simulta- 
neous release of both relaxing and contracting fac- 
tors, the response of the smooth muscle represented 
the sum of these opposing effects. 
Arterial endothelial cells release nitric oxide in 
response to stimulation with acetylcholine. 23 
Whether nitric oxide is released in response to ace@- 
choline in sodded endothelial cells is unknown at this 
time. Direct measurement of nitric oxide/total NO x 
in the effluent of sodded compared with superfusate 
through the direct line (stainless teel tube) was 
equivocal with chemilumenscence (preliminary un- 
published observations from our laboratory). Non- 
specific staining of unsodded grafts for ecNOS was 
observed and may reflect problems with specificity of 
the antibody. 
Four other endothelium-derived vasoactive fac- 
tors were measured irectly from the effluent of sod- 
ded and unsodded grafts: CNP, endothelin-1, 6-keto 
prostaglandin Fl~ (the stable metabolite ofprostacy- 
din), and thromboxane B 2 (the stable metabolite of 
thromboxane A2). 
C-type natriuretic peptide has been implicated as 
a possible endothelium-derived hyperpolarizing fac- 
tor. 24 Arteries are less responsive to CNP than veins, 
which may account for less robust relaxations of the 
arterial bioassay rings to graft effluent. In those grafts 
in which it was possible to detect CNP in the effluent, 
there was increased release in the sodded versus the 
unsodded grafts. There was also more positive stain- 
ing for CNP in the sodded grafts. Endothelin-1 was 
produced by cells of sodded and unsodded grafts. 
Although there was little evidence of a continuous 
lining of cells on the unsodded graft, there may have 
been enough cells of endothelial or other origin 
trapped within the nodes of the graft material to 
respond to the agonists used in the bioassay experi- 
ments. 
Not only were CNP and endothelin-1 measured 
in the effluent, but they also could be identified by 
immunohistochemistry in cellular elements differen- 
tially distributed throughout the sodded and unsod- 
ded grafts. Positive staining for CNP, endothelin-1, 
and ecNOS in the cells lining the lumen of the 
sodded grafts supports the suggestion that the sod- 
ded grafts have a viable endothelial layer adjacent to 
the lumen. Nonspecific staining of graft material to 
CNP and endothelin-1 could reflect he presence of 
peptide released from cellular elements during the 
bioassay experiments and their subsequent binding 
to the graft material. 
Effluent from sodded and unsodded grafts 
showed significant amounts of prostanoids. Whereas 
the functional studies with bioassay rings showed 
relaxations only to acetylcholine in the sodded grafts, 
only stimulation of the sodded graft with the calcium 
ionophore A23187 showed a significant increase in 
6-keto prostaglandin FI~. It is possible that acetyl- 
choline stimulates release of relaxing factors other 
than prostacyclin. 2s,26 
Positive staining for smooth-muscle h avy-chain 
myosin is characteristic of a differentiated layer of 
smooth-muscle c lls 27 under the cells lining the lu; 
men of sodded but not unsodded grafts. This result 
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suggests that a "neo-vessel" is forming in the lumen 
of  the sodded ePTFE graft. I t  remains to be seen 
whether  the dimensions of  this "neo-vessel" would  
be l imited by flow characteristics in the graft as in the 
neoint ima of  unsodded prosthetic and vein 
grafts. 2s-a° CNP,  endothel in-1,  and nitric oxide may 
influence differentiation and growth of  smooth-mus-  
cle cells. 3133 
Sodded grafts have numerous advantages that 
may promote  long-term patency. Sodded grafts con- 
tain a l ining o f  cells with anatomic haracteristics of
endothel ial  cells. In addit ion, endothel ial  ceils lack 
constitutive xpression of  a cell surface l igand for 
platelet receptors 34 and secrete ndothel ium-der ived 
relaxing factors like prostacyclin and perhaps nitric 
oxide, which would  reduce platelet aggregation. 35-a7 
Unsodded grafts, in contrast, produced significantly 
more thromboxane 8 2 than the cells on the sodded 
grafts, which may be associated with increased plate- 
let aggregation. 3<38 Thus decreased patency in 
small-diameter grafts may not  only be due to the 
mechanical surface but  also to release o f  factors by 
cells infiltrating unsodded grafts, which promote  
platelet aggregation. 34
In conclusion, this study confirms observations of  
others l°a~ that sodding o f  autogenous endothel ial  
ceils onto ePTFE grafts produces a confluent layer o f  
cells l ining the grafts 4 to 6 weeks later. This study 
extends previous observations to indicate that the 
cells l ining the sodded grafts produce factors that 
have the potential  to influence tone and growth of  
underlying cellular elements and affect aggregation 
and adhesion of  b lood borne elements. 
The authors acknowledge Dr. Gary Owens of the Uni- 
versity of Virginia, who generously supplied antibodies for 
the ct-actin and heavy-chain myosin, and the technical help 
of Mr. William Anding, Mrs. Arlene Morris, Mr. Steve 
Ziesmer, and Mr. Kevin Rud. 
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